Full name
EUROPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
21.1 - Manufacture of basic pharmaceutical products
21.2 - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,4 | 2,1 | 1,1 | -49,2 |
EBITDA | 4 | 2,7 | 1,2 | -54,7 |
Short time liabilities | 9,3 | 12 | 14 | 16,9 |
Equity capital | 5,1 | 4,5 | 3,7 | -17,9 |
Operating profit (EBIT) | 3,4 | 2,2 | 0,7 | -67,8 |
Assets | 15,1 | 17,2 | 18,2 | 6,1 |
Net profit (loss) | 3,1 | 1,6 | 0,8 | -48,7 |
Cash | 4,5 | 7,6 | 0,2 | -96,9 |
Liabilities and provisions for liabilities | 10 | 12,7 | 14,5 | 14,6 |
Net income from sale | 83,8 | 79,9 | 71,5 | -10,5 |
Working assets | 12,7 | 15 | 15,9 | 5,7 |
Depreciation | 0,6 | 0,5 | 0,5 | 0,2 |
% | % | % | p.p. | |
Profitability of capital | 60,6 | 36,7 | 22,9 | -13,8 |
Equity capital to total assets | 33,5 | 26,2 | 20,2 | -6 |
Gross profit margin | 4,1 | 2,7 | 1,5 | -1,2 |
EBITDA Margin | 4,8 | 3,4 | 1,7 | -1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 41 | 55 | 71 | 16 |
Current financial liquidity indicator | 1.3592002391815186 | 1.2425709962844849 | 1.1289057731628418 | -0,1 |
Net dept to EBITDA | -0.7730569839477539 | -2.5769410133361816 | -0.12822405993938446 | 2,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane